CU CHEMIE UETIKON GMBH

Overview

CU CHEMIE UETIKON GMBH is an active pharmaceutical ingredient (API) supplier with 7 active FDA Type II Drug Master Files, covering 4-PHENYLBUTYRIC ACID SODIUM SALT; DALFAMPRIDINE; KETAMINE HYDROCHLORIDE; METHIMAZOLE; PHENYLACETIC ACID SODIUM SALT; S-KETAMINE HYDROCHLORIDE.

API / Drug Master Files

CU CHEMIE UETIKON GMBH holds 7 active (8 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• DALFAMPRIDINEActive2004-11-29
• S-KETAMINE HYDROCHLORIDEActive2003-07-31
• PHENYLACETIC ACID SODIUM SALTActive1993-06-04
• TERAZOSIN HYDROCHLORIDE ANHYDROUSActive1993-01-11
• 4-PHENYLBUTYRIC ACID SODIUM SALTActive1992-06-08
• KETAMINE HYDROCHLORIDEActive1988-09-22
• METHIMAZOLEActive1986-04-23
• AZELAIC ACIDInactive1994-04-05

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to CU CHEMIE UETIKON GMBH in our records. PharmaTek screens the full directory against live FDA enforcement data.